Clinical Trials Directory

Trials / Completed

CompletedNCT05194306

PERTRIAL - Perla® Preservation Solution

Evaluation of the Safety and Performance of Perla® Preservation Solution for Donor Liver and Kidney for Transplantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Advanced Life Solutions · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Perla® is a Cold Preservation Solution, with purpose to wash out, preserve during transport liver and kidney grafts in optimal conditions from the donor to the recipient. The purpose of the PERTRIAL clinical investigation is to demonstrate the Performance and Safety of Perla® Cold Preservation solution.

Conditions

Interventions

TypeNameDescription
DRUGPerla® Cold Preservation solutionPerla® must be cooled to 2° to 6 °C prior to use. The cold Preservation Solution is used to flush the isolated organ immediately before removal from the donor and/or immediately after removal from the donor. The solution is then left in the organ vasculature during hypothermic storage and transportation.

Timeline

Start date
2021-12-11
Primary completion
2022-04-30
Completion
2022-04-30
First posted
2022-01-18
Last updated
2023-05-17

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05194306. Inclusion in this directory is not an endorsement.